Influence of extended mutations of the HIV-1 transframe protein p6* on Nef-dependent viral replication and infectivity in vitro

Virology

Volumn 387, Issue 1, 2009, Pages 200-210

  Leiherer, Andreas ^a   Ludwig, Christine ^a   Wagner, Ralf ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Competition assay; Frameshift; Gag Pol; HIV 1; Nef; p6*; p6pol; Transframe protein; Viral infectivity

Indexed keywords

GAG PROTEIN; NEF PROTEIN; POL PROTEIN; PROTEIN P6; STRUCTURAL PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; CELL CULTURE; GENE INSERTION SEQUENCE; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; LIFE CYCLE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROVIRUS; VIROGENESIS; VIRUS INFECTIVITY; VIRUS MUTATION; VIRUS REPLICATION;

CELL LINE; EPITHELIAL CELLS; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HELA CELLS; HIV-1; HUMANS; MUTATION; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; VIRION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 63549109607     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.01.042     Document Type: Article

References (63)

1. Adachi A., Gendelman H.E., Koenig S., Folks T., Willey R., Rabson A., and Martin M.A. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59 (1986) 284-291
2. Alexander L., Weiskopf E., Greenough T.C., Gaddis N.C., Auerbach M.R., Malim M.H., O'Brien S.J., Walker B.D., Sullivan J.L., and Desrosiers R.C. Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection. J. Virol. 74 (2000) 4361-4376
3. Almog N., Roller R., Arad G., Passi-Even L., Wainberg M.A., and Kotler M. A p6Pol-protease fusion protein is present in mature particles of human immunodeficiency virus type 1. J. Virol. 70 (1996) 7228-7232
4. Barrie K.A., Perez E.E., Lamers S.L., Farmerie W.G., Dunn B.M., Sleasman J.W., and Goodenow M.M. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1. Virology 219 (1996) 407-416
5. Beissinger M., Paulus C., Bayer P., Wolf H., Rosch P., and Wagner R. Sequence-specific resonance assignments of the 1H-NMR spectra and structural characterization in solution of the HIV-1 transframe protein p6. Eur. J. Biochem. 237 (1996) 383-392
6. Bleiber G., Peters S., Martinez R., Cmarko D., Meylan P., and Telenti A. The central region of human immunodeficiency virus type 1 p6 protein (Gag residues S14-I31) is dispensable for the virus in vitro. J. Gen. Virol. 85 (2004) 921-927
7. Cao J., McNevin J., McSweyn M., Liu Y., Mullins J.I., and McElrath M.J. Novel CTL escape by a three amino acid insertion in HIV-1 p6Pol and p6Gag late domain associated with drug resistance. J. Virol. (2007)
8. Chen N., Morag A., Almog N., Blumenzweig I., Dreazin O., and Kotler M. Extended nucleocapsid protein is cleaved from the Gag-Pol precursor of human immunodeficiency virus type 1. J. Gen. Virol. 82 (2001) 581-590
9. Chiu H.C., Wang F.D., Chen Y.M., and Wang C.T. Effects of human immunodeficiency virus type 1 transframe protein p6* mutations on viral protease-mediated Gag processing. J. Gen. Virol. 87 (2006) 2041-2046
10. Chowers M.Y., Spina C.A., Kwoh T.J., Fitch N.J., Richman D.D., and Guatelli J.C. Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene. J. Virol. 68 (1994) 2906-2914
11. Ciuffi A., Munoz M., Bleiber G., Favre M., Stutz F., Telenti A., and Meylan P.R. Interactions of processed Nef (58-206) with virion proteins of HIV type 1. AIDS Res. Hum. Retroviruses 20 (2004) 399-407
12. Coates K., Cooke S.J., Mann D.A., and Harris M.P. Protein kinase C-mediated phosphorylation of HIV-I nef in human cell lines. J. Biol. Chem. 272 (1997) 12289-12294
13. Costa L.J., Zheng Y.H., Sabotic J., Mak J., Fackler O.T., and Peterlin B.M. Nef binds p6* in GagPol during replication of human immunodeficiency virus type 1. J. Virol. 78 (2004) 5311-5323
14. D'Aloja P., Olivetta E., Bona R., Nappi F., Pedacchia D., Pugliese K., Ferrari G., Verani P., and Federico M. gag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants. J. Virol. 72 (1998) 4308-4319
15. D'Aloja P., Santarcangelo A.C., Arold S., Baur A., and Federico M. Genetic and functional analysis of the human immunodeficiency virus (HIV) type 1-inhibiting F12-HIVnef allele. J. Gen. Virol. 82 (2001) 2735-2745
16. Day J.R., Munk C., and Guatelli J.C. The membrane-proximal tyrosine-based sorting signal of human immunodeficiency virus type 1 gp41 is required for optimal viral infectivity. J. Virol. 78 (2004) 1069-1079
17. Dayhoff, M.O., von Eck, R., and Park, C.M., 1972. A model for evolutionary change in proteins. Atlas of protein sequence and structure 5, 89-99.
18. Fackler O.T., D'Aloja P., Baur A.S., Federico M., and Peterlin B.M. Nef from human immunodeficiency virus type 1(F12) inhibits viral production and infectivity. J. Virol. 75 (2001) 6601-6608
19. Federico M., Nappi F., Ferrari G., Chelucci C., Mavilio F., and Verani P. A nonproducer, interfering human immunodeficiency virus (HIV) type 1 provirus can be transduced through a murine leukemia virus-based retroviral vector: recovery of an anti-HIV mouse/human pseudotype retrovirus. J. Virol. 69 (1995) 6618-6626
20. Federico M., Bona R., D'Aloja P., Baiocchi M., Pugliese K., Nappi F., Chelucci C., Mavilio F., and Verani P. Anti-HIV viral interference induced by retroviral vectors expressing a nonproducer HIV-1 variant. Acta Haematol. 95 (1996) 199-203
21. Freund J., Kellner R., Konvalinka J., Wolber V., Krausslich H.G., and Kalbitzer H.R. A possible regulation of negative factor (Nef) activity of human immunodeficiency virus type 1 by the viral protease. Eur. J. Biochem. 223 (1994) 589-593
22. Gaedigk-Nitschko K., Schon A., Wachinger G., Erfle V., and Kohleisen B. Cleavage of recombinant and cell derived human immunodeficiency virus 1 (HIV-1) Nef protein by HIV-1 protease. FEBS Lett. 357 (1995) 275-278
23. Giese S.I., Woerz I., Homann S., Tibroni N., Geyer M., and Fackler O.T. Specific and distinct determinants mediate membrane binding and lipid raft incorporation of HIV-1(SF2) Nef. Virology 355 (2006) 175-191
24. Greenway A.L., McPhee D.A., Grgacic E., Hewish D., Lucantoni A., Macreadie I., and Azad A. Nef 27, but not the Nef 25 isoform of human immunodeficiency virus-type 1 pNL4.3 down-regulates surface CD4 and IL-2R expression in peripheral blood mononuclear cells and transformed T cells. Virology 198 (1994) 245-256
25. Hill M.K., Hooker C.W., Harrich D., Crowe S.M., and Mak J. Gag-Pol supplied in trans is efficiently packaged and supports viral function in human immunodeficiency virus type 1. J. Virol. 75 (2001) 6835-6840
26. Hill M.K., Shehu-Xhilaga M., Crowe S.M., and Mak J. Proline residues within spacer peptide p1 are important for human immunodeficiency virus type 1 infectivity, protein processing, and genomic RNA dimer stability. J. Virol. 76 (2002) 11245-11253
27. Hill M., Tachedjian G., and Mak J. The packaging and maturation of the HIV-1 Pol proteins. Curr. HIV. Res. 3 (2005) 73-85
28. Hill M.K., Bellamy-McIntyre A., Vella L.J., Campbell S.M., Marshall J.A., Tachedjian G., and Mak J. Alteration of the proline at position 7 of the HIV-1 spacer peptide p1 suppresses viral infectivity in a strain dependent manner. Curr. HIV. Res. 5 (2007) 69-78
29. Ho S.K., Coman R.M., Bunger J.C., Rose S.L., O'Brien P., Munoz I., Dunn B.M., Sleasman J.W., and Goodenow M.M. Drug-associated changes in amino acid residues in Gag p2, p7(NC), and p6(Gag)/p6(Pol) in human immunodeficiency virus type 1 (HIV-1) display a dominant effect on replicative fitness and drug response. Virology 378 (2008) 272-281
30. Ibe S., Shibata N., Utsumi M., and Kaneda T. Selection of human immunodeficiency virus type 1 variants with an insertion mutation in the p6(gag) and p6(pol) genes under highly active antiretroviral therapy. Microbiol. Immunol. 47 (2003) 71-79
31. Ibe S., Shigemi U., Sawaki K., Fujisaki S., Hattori J., Yokomaku Y., Mamiya N., Hamaguchi M., and Kaneda T. Analysis of near full-length genomic sequences of drug-resistant HIV-1 spreading among therapy-naïve individuals in Nagoya, Japan: amino acid mutations associated with viral replication activity. AIDS Res. Hum. Retroviruses 24 (2008) 1121-1125
32. Jacks T., Power M.D., Masiarz F.R., Luciw P.A., Barr P.J., and Varmus H.E. Characterization of ribosomal frameshifting in HIV-1 gag-pol expression. Nature 331 (1988) 280-283
33. Kimpton J., and Emerman M. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. J. Virol. 66 (1992) 2232-2239
34. Kotov A., Zhou J., Flicker P., and Aiken C. Association of Nef with the human immunodeficiency virus type 1 core. J. Virol. 73 (1999) 8824-8830
35. Louis J.M., Clore G.M., and Gronenborn A.M. Autoprocessing of HIV-1 protease is tightly coupled to protein folding. Nat. Struct. Biol. 6 (1999) 868-875
36. Ludwig C., Leiherer A., and Wagner R. Importance of protease cleavage sites within and flanking HIV-1 transframe protein p6* for spatiotemporal regulation of protease activation. J. Virol. 82 (2008) 4573-4584
37. Luo T., and Garcia J.V. The association of Nef with a cellular serine/threonine kinase and its enhancement of infectivity are viral isolate dependent. J. Virol. 70 (1996) 6493-6496
38. Marlowe N., Flys T., Hackett Jr. J., Schumaker M., Jackson J.B., and Eshleman S.H. Analysis of insertions and deletions in the gag p6 region of diverse HIV type 1 strains. HIV Prevention Trials Network; Adult AIDS Clinical Trials Groups. AIDS Res. Hum. Retroviruses 20 (2004) 1119-1125
39. Miller M.D., Warmerdam M.T., Ferrell S.S., Benitez R., and Greene W.C. Intravirion generation of the C-terminal core domain of HIV-1 Nef by the HIV-1 protease is insufficient to enhance viral infectivity. Virology 234 (1997) 215-225
40. Olivetta E., Pugliese K., Bona R., D'Aloja P., Ferrantelli F., Santarcangelo A.C., Mattia G., Verani P., and Federico M. cis expression of the F12 human immunodeficiency virus (HIV) Nef allele transforms the highly productive NL4-3 HIV type 1 to a replication-defective strain: involvement of both Env gp41 and CD4 intracytoplasmic tails. J. Virol. 74 (2000) 483-492
41. Ono T., Iwatani Y., Nishimura A., Ishimoto A., and Sakai H. Functional association between the nef gene product and gag-pol region of HIV-1. FEBS Lett. 466 (2000) 233-238
42. Pandori M.W., Fitch N.J., Craig H.M., Richman D.D., Spina C.A., and Guatelli J.C. Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein. J. Virol. 70 (1996) 4283-4290
43. Paulus C., Hellebrand S., Tessmer U., Wolf H., Krausslich H.G., and Wagner R. Competitive inhibition of human immunodeficiency virus type-1 protease by the Gag-Pol transframe protein. J. Biol. Chem. 274 (1999) 21539-21543
44. Paulus C., Ludwig C., and Wagner R. Contribution of the Gag-Pol transframe domain p6* and its coding sequence to morphogenesis and replication of human immunodeficiency virus type 1. Virology 330 (2004) 271-283
45. Peters S., Munoz M., Yerly S., Sanchez-Merino V., Lopez-Galindez C., Perrin L., Larder B., Cmarko D., Fakan S., Meylan P., and Telenti A. Resistance to nucleoside analog reverse transcriptase inhibitors mediated by human immunodeficiency virus type 1 p6 protein. J. Virol. 75 (2001) 9644-9653
46. Pettit S.C., Gulnik S., Everitt L., and Kaplan A.H. The dimer interfaces of protease and extra-protease domains influence the activation of protease and the specificity of GagPol cleavage. J. Virol. 77 (2003) 366-374
47. Ratner L., Haseltine W., Patarca R., Livak K.J., Starcich B., Josephs S.F., Doran E.R., Rafalski J.A., Whitehorn E.A., and Baumeister K. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 313 (1985) 277-284
48. Ratner L., Fisher A., Jagodzinski L.L., Mitsuya H., Liou R.S., Gallo R.C., and Wong-Staal F. Complete nucleotide sequences of functional clones of the AIDS virus. AIDS Res. Hum. Retroviruses 3 (1987) 57-69
49. Reil H., Kollmus H., Weidle U.H., and Hauser H. A heptanucleotide sequence mediates ribosomal frameshifting in mammalian cells. J. Virol. 67 (1993) 5579-5584
50. Sawai E.T., Baur A.S., Peterlin B.M., Levy J.A., and Cheng-Mayer C. A conserved domain and membrane targeting of Nef from HIV and SIV are required for association with a cellular serine kinase activity. J. Biol. Chem. 270 (1995) 15307-15314
51. Schramm H.J., Billich A., Jaeger E., Rucknagel K.P., Arnold G., and Schramm W. The inhibition of HIV-1 protease by interface peptides. Biochem. Biophys. Res. Commun. 194 (1993) 595-600
52. Shehu-Xhilaga M., Kraeusslich H.G., Pettit S., Swanstrom R., Lee J.Y., Marshall J.A., Crowe S.M., and Mak J. Proteolytic processing of the p2/nucleocapsid cleavage site is critical for human immunodeficiency virus type 1 RNA dimer maturation. J. Virol. 75 (2001) 9156-9164
53. Song Y.H., Meng Z.F., Xing H., Ruan Y.H., Li X.P., Xin R.L., Ma P.F., Peng H., and Shao Y. Analysis of HIV-1 CRF07_BC gag p6 sequences indicating novel deletions in the central region of p6. Arch. Virol. 152 (2007) 1553-1558
54. Tokunaga K., Kojima A., Kurata T., Ikuta K., Akari H., Koyama A.H., Kawamura M., Inubushi R., Shimano R., and Adachi A. Enhancement of human immunodeficiency virus type 1 infectivity by Nef is producer cell-dependent. J. Gen. Virol. 79 Pt 10 (1998) 2447-2453
55. VerPlank L., Bouamr F., LaGrassa T.J., Agresta B., Kikonyogo A., Leis J., and Carter C.A. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag). Proc. Natl. Acad. Sci. U. S. A 98 (2001) 7724-7729
56. Wain-Hobson S., Sonigo P., Danos O., Cole S., and Alizon M. Nucleotide sequence of the AIDS virus, LAV. Cell 40 (1985) 9-17
57. Walter A.E., Turner D.H., Kim J., Lyttle M.H., Muller P., Mathews D.H., and Zuker M. Coaxial stacking of helixes enhances binding of oligoribonucleotides and improves predictions of RNA folding. Proc. Natl. Acad. Sci. U. S. A 91 (1994) 9218-9222
58. Welker R., Kottler H., Kalbitzer H.R., and Krausslich H.G. Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase. Virology 219 (1996) 228-236
59. Whitehurst N., Chappey C., Petropoulos C., Parkin N., and Gamarnik A. Polymorphisms in p1-p6/p6* of HIV type 1 can delay protease autoprocessing and increase drug susceptibility. AIDS Res. Hum. Retroviruses 19 (2003) 779-784
60. Wilson W., Braddock M., Adams S.E., Rathjen P.D., Kingsman S.M., and Kingsman A.J. HIV expression strategies: ribosomal frameshifting is directed by a short sequence in both mammalian and yeast systems. Cell 55 (1988) 1159-1169
61. Wolf H., Modrow S., Soutschek M., Motz M., Grunow R., Döbl H., and von Baehr R. Production, mapping and biological characterization of monoclonal antibodies against core protein (p24) of the human immunodeficiency virus. AIDS-Forsch 1 (1990) 16-18
62. Zuker M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31 (2003) 3406-3415
63. Zybarth G., Krausslich H.G., Partin K., and Carter C. Proteolytic activity of novel human immunodeficiency virus type 1 proteinase proteins from a precursor with a blocking mutation at the N terminus of the PR domain. J. Virol. 68 (1994) 240-250